Recommended Methods for the Identification and Analysis of Cannabis and Cannabis Products PDF Download

Author: United Nations Office on Drugs and Crime
Publisher: United Nations Publications
ISBN: 9789211482423
Category : Business & Economics
Languages : en
Pages : 0

View

Book Description
Cannabis products are the most widely trafficked drugs worldwide, and it also remains the most widely used drug worldwide. At the same time, production methods have become increasingly sophisticated, resulting in the availability in illicit markets of a wide range of cannabis products. This updated and significantly revised manual has been prepared taking into account both developments in analytical technology and advances in the science of cannabis. It is aimed at the harmonization and establishment of recommended methods of analysis for national drug analysis laboratories. The manual suggests approaches that may assist drug analysts in the selection of methods appropriate to the sample under examination and provide data suitable for the purpose at hand, leaving room also for adaptation to the level of sophistication of different laboratories and the various legal needs.

Author:
Publisher: Elsevier
ISBN: 0444643427
Category : Science
Languages : en
Pages : 518

View

Book Description
Analysis of Cannabis, Volume 91, contains a wide variety of information on the analysis of cannabis and hemp, including cannabinoids, terpenes, volatile solvents and metals. Specific chapters in this new release include the Comprehensive Analytical Testing of Cannabis and Hemp, Machine Learning Methods for Inferring Chemotype Profiles in Cannabis Sativa, Recent Analytical Methodologies and Strategic Pharmacological Applications of Cannabinoids, Analysis of Cannabinoids in Plants, Marijuana Products and Biological Tissues, LC-based (UV and MS) Analysis of Cannabinoids, Testing Cannabis Samples for Heavy Metal Contamination using Microwave Assisted Digestion and ICP-MS Techniques, Applications of GC-MS Techniques for Cannabis Analysis, and much more. Contains diverse, state-of-the-art methodologies for the analyses of cannabinoids and terpenes in a variety of matrices Analyzes different cannabis and hemp-based products Provides the expertise of leading contributors from an international board of authors

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309453070
Category : Science
Languages : en
Pages : 487

View

Book Description
Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

Author: Suman Chandra
Publisher: Springer
ISBN: 3319545647
Category : Science
Languages : en
Pages : 474

View

Book Description
This book highlights current Cannabis research: its botany, authentication, biotechnology, in vitro propagation, chemistry, cannabinoids biosynthesis, metabolomics, genomics, biomass production, quality control, and pharmacology. Cannabis sativa L. (Family: Cannabaceae) is one of the oldest sources of fiber, food and medicine. This plant has been of interest to researchers, general public and media not only due to its medicinal properties but also the controversy surrounding its illicit use. Cannabis has a long history of medicinal use in the Middle East and Asia, being first introduced as a medicine in Western Europe in the early 19th century. Due to its numerous natural constituents, Cannabis is considered a chemically complex species. It contains a unique class of terpeno-phenolic compounds (cannabinoids or phytocannabinoids), which have been extensively studied since the discovery of the chemical structure of tetrah ydrocannabinol (Δ9-THC), commonly known as THC, the main constituent responsible for the plant’s psychoactive effects. An additionally important cannabinoid of current interest is Cannabidiol (CBD). There has been a significant interest in CBD and CBD oil (extract of CBD rich Cannabis) over the last few years because of its reported activity as an antiepileptic agent, particularly its potential use in the treatment of intractable epilepsy in children.

Author: Kathy Knutson
Publisher: Academic Press
ISBN: 0128195126
Category : Science
Languages : en
Pages : 238

View

Book Description
Food Safety Lessons for Cannabis-Infused Edibles details the world of cannabis-infused edibles and the way its manufacturing is evolving as the industry moves from isolation to regulatory compliance. The cannabis industry has unique challenges as cannabis-infused edibles are not regulated as food, drugs or dietary supplements at the federal level. Despite these current conditions, the industry is aware of the need to examine the safety of these edibles and prepare for a future of federal compliance. The book looks at the cannabis industry through a scientific lens to increase awareness and expertise in food safety within the field of cannabis-infused edibles. Includes lessons learned by the food industry Presents unique challenges in the manufacture of cannabis-infused edibles Provides information of US Federal food safety compliance Explores the current state of research regarding edibles

Author: British Medical Association
Publisher: CRC Press
ISBN: 9789057023187
Category : Medical
Languages : en
Pages : 164

View

Book Description
At the last Annual Representative Meeting of the British Medical Association a motion was passed that `certain additional cannabinoids should be legalized for wider medicinal use.'' This report supports this landmark statement by reviewing the scientific evidence for the therapeutic use of cannabinoids and sets the agenda for change. It will be welcomed by those who believe that cannabinoids can be used in medical treatment. The report discusses in a clear and readable form the use and adverse effects of the drug for nausea, multiple sclerosis, pain, epilepsy, glaucoma, and asthma.

Author: Mahmoud A. ElSohly
Publisher: Springer Science & Business Media
ISBN: 1592599478
Category : Medical
Languages : en
Pages : 322

View

Book Description
Although primarily used today as one of the most prevalent illicit leisure drugs, the use of Cannabis sativa L., commonly referred to as marijuana, for medicinal purposes has been reported for more than 5000 years. Marijuana use has been shown to create numerous health problems, and, consequently, the expanding use beyond medical purposes into recreational use (abuse) resulted in control of the drug through international treaties. Much research has been carried out over the past few decades following the identification of the chemical structure of THC in 1964. The purpose of Marijuana and the Cannabinoids is to present in a single volume the comprehensive knowledge and experience of renowned researchers and scientists. Each chapter is written independently by an expert in his/her field of endeavor, ranging from the botany, the constituents, the chemistry and pharmacokinetics, the effects and consequences of illicit use on the human body, to the therapeutic potential of the cannabinoids.

Author: Tom Decorte
Publisher: Archway Publishing
ISBN: 1480861448
Category : Political Science
Languages : en
Pages : 120

View

Book Description
With the legalization of recreational cannabis markets in Uruguay, Canada, and several U.S. states, a breakthrough in conventional cannabis policy is emerging. But legalization is not a binary choice between prohibition and some regulated commercial model (like alcohol). A commercial market is just one of many ways to implement legalizationand moving directly from prohibition to commercial legalization leaps from one extreme to the other. Tom Decorte, a criminologist and anthropologist at Ghent University (Belgium), who has published numerous articles on substance use, cannabis markets, and local drug monitoring systems, argues that most of us are bypassing other, safer forms of legalization, including the nonprofit model. He explores topics such as: Why we need to consider regulation of cannabis markets. How local authorities and grassroots movements are advocating change. How to best design and implement approaches to legalization. Join the author as he examines international regulatory controls over cannabis possession, use, and cultivationas well as a framework for regulating the cannabis market via a nonprofit corporate model that promotes public health and safety over profits

Author: Brian F Thomas
Publisher: Elsevier
ISBN: 0128046708
Category : Science
Languages : en
Pages : 132

View

Book Description
A volume in the Emerging Issues in Analytical Chemistry series, The Analytical Chemistry of Cannabis: Quality Assessment, Assurance, and Regulation of Medicinal Marijuana and Cannabinoid Preparations provides analytical chemistry methods that address the latest issues surrounding cannabis-based products. The plethora of marketed strains of cannabis and cannabinoid-containing products, combined with the lack of industry standards and labelling requirements, adds to the general perception of poor quality control and limited product oversight. The methods described in this leading-edge volume help to support the manufacturing, labelling, and distribution of safe and consistent products with known chemical content and demonstrated performance characteristics. It treats analytical chemistry within the context of the diverse issues surrounding medicinal and recreational cannabis in a manner designed to foster understanding and rational perspective in non-scientist stakeholders as well as scientists who are concerned with bringing a necessary degree of order to a field now characterized by confusion and contradiction. The Emerging Issues in Analytical Chemistry series is published in partnership with RTI International and edited by Brian F. Thomas. Please be sure to check out our other featured volumes: Hackney, Anthony C. Exercise, Sport, and Bioanalytical Chemistry: Principles and Practice, 9780128092064, March 2016. Tanna, Sangeeta and Lawson, Graham. Analytical Chemistry for Assessing Medication Adherence, 9780128054635, April 2016. Rao, Vikram, Knight, Rob, and Stoner, Brian. Sustainable Shale Oil and Gas: Analytical Chemistry, Biochemistry, and Geochemistry Methods, 9780128103890, forthcoming September 2016. Farsalinos, Konstantinos, et al. Analytical Assessment of e-Cigarettes: From Contents to Chemical and Particle Exposure Profiles, 9780128112410, forthcoming November 2016. Addresses current and emerging analytical chemistry methods—an approach that is unique among the literature on this topic Presents information from a broad perspective of the issues in a single compact volume Employs language comprehensible to non-technical stakeholders as well as to specialists in analytical chemistry

Author: David S. Younger
Publisher:
ISBN: 9781536145663
Category : Marijuana
Languages : en
Pages : 144

View

Book Description
The cultural, scientific and legislative divide created by vigorous debates over the legalization of medical marijuana is giving way to a new synergy among community stakeholders across the United States. The goal is to improve access to medical marijuana for patients with refractory debilitating neurological disorders, cancer, and chronic pain as an alternative to ineffective pharmacotherapy and potentially addictive pain medications. The ultimate test of our nations resolve to ensure the welfare of our sickest patients is the enactment and implement of effective public health reform in the area of medical marijuana, also known as medical cannabis.This book evolved out of the present need for a definitive volume on the science and public health aspects of medical cannabis to fuel this national narrative. The ethnographic research presented in the concluding chapter was inspired by Professor Miriam W. Boeri and colleagues, at Bentley University in Waltham, MA. They examined views of community stakeholders including medical marijuana dispensary entrepreneurs, health care professionals, and patients in a state that legalized medical marijuana in 2013, yet there continued to be confusion and misunderstandings in the interpretation and implementation of medical marijuana guidelines during the period of policy shifts. Apparent gaps in policy development and implementation signaled the urgency for a comparison study addressing stakeholder views in New York State, where its medical marijuana program has legally dispensed the drug since 2014. The resulting pilot study was carried out in the Division of Health Policy and Management of the City University of New York School of Public Health. The research model incorporated ethnographic and grounded methodologies to detail the views of physicians, pharmacists, educators, patients, and entrepreneur stakeholders; with triangulation of data and application of dominant themes into a socioecological framework model to identify areas of public health policy reform. The findings of this study detail that New York, like other states that recently legalized the dispensation of medical marijuana, faces challenges beyond policy transparency, communication and education explicitly to improve the implementation process for applying and registering medical cannabis dispensaries, referring physicians, and qualified patient recipients.Ken Langone, Chairman of the Board of New York University Langone Health, and Steven Galetta, Chair of Neurology in the School of Medicine, where the authors is senior staff in neuroepidemiology, motivated him to pursue doctoral training in Health Policy and Management. The author has had the good fortune of interacting with thought-provoking medical students, neurology trainees, public health doctoral students, and professors who reinforce the high ethical standards in medical and public health practice and research. However, his patients still educate him in empathy and humanity. The author is grateful to his family, including his spouse Holly and sons Adam and Seth, who serve as his daily compass, encouraging him to take on projects that promote core values of medicine and humanity.